ProfileGDS4132 / 209750_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 85% 87% 84% 82% 90% 87% 86% 90% 87% 87% 85% 87% 86% 89% 88% 91% 86% 86% 82% 87% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101319.1185
GSM201543Muscle PCOS pioglitazone 121333.58687
GSM201544Muscle PCOS pioglitazone 161341.52184
GSM201545Muscle PCOS pioglitazone 201322.57882
GSM201829Muscle PCOS pioglitazone 231452.59290
GSM201830Muscle PCOS pioglitazon 251355.17987
GSM201831Muscle PCOS pioglitazone 271343.75786
GSM201832Muscle PCOS pioglitazone 31423.38190
GSM201833Muscle PCOS pioglitazone 41350.32987
GSM201834Muscle PCOS pioglitazone 81374.79187
GSM201835Muscle PCOS after pioglitazone 102337.22785
GSM201836Muscle PCOS after pioglitazone 122381.54787
GSM201837Muscle PCOS after pioglitazone 162344.96886
GSM201838Muscle PCOS after pioglitazone 202448.11289
GSM201839Muscle PCOS after pioglitazone 232390.37788
GSM201840Muscle PCOS after pioglitazone 252502.21391
GSM201841Muscle PCOS after pioglitazone 272346.29886
GSM201842Muscle PCOS after pioglitazone 32324.71486
GSM201843Muscle PCOS after pioglitazone 42299.27582
GSM201844Muscle PCOS after pioglitazone 82391.63587